HeartStitch said today it won CE Mark approval in the European Union for its CoAp Pro device designed for mitral valve remodeling and repair. The Fountain Valley, Calif.-based company said its CoAp Pro device is designed to allow physicians to remodel mitral valve leaflets to re-establish proper coaptation. “I am especially pleased to see HeartStitch receive […]
HeartStitch
HeartStitch wins CE Mark for Trans-Apical Access and Closure device
HeartStitch said today it won CE Mark approval in the European Union for its suture-based Trans-Apical Access and Closure device. The Trans-Apical Access and Closure device is designed to provide percutaneous trans-apical access for structural heart procedures and closures. The system emulates surgical closure without need for open heart surgery or limited thoractomy access during left-heart […]
HeartStitch touts tricuspid repair feasibility cases
Structural heart focused medtech company HeartStitch said today that its HeartStitch Remo Pro suture technique was used in a world first procedure to repair the tricuspid valve of two patients as part of a feasibility trial of the technique and the supporting technology. The procedures were performed by Dr. Yuri Pya at Astana, Kazakhstan’s National Research […]
HeartStitch touts 1st-in-human use in aortic valve surgery
Structural heart focused HeartStitch today touted the 1st-in-man use of the company’s HeartStitch technology in a transapical access and closure procedure at the National Cardiac Research Center in Astana, Kazakhstan. The 2 procedures were performed by device inventor, HeartStitch co-founder and CEO Dr. Anthony Nobles and CMO Dr. Michael Mullen, the company said. “This exciting technology […]
ResMed shuffles the deck at Brightree; taps Mellott as new CEO | Personnel Moves June 21, 2016
ResMed shuffles the deck at Brightree; taps Mellott as new CEO ResMed (NYSE:RMD) yesterday announced a mix-up at its Brightree business, tapping home medical equipment industry vet Matt Mellott as its new CEO and Bobby Ghoshal as its new COO. Former Brightree CEO and prez Dave Cormack will transition into a multi-year advisory role, the company […]
Novartis pharma head Epstein steps away, most recent in string of top-level turnovers | Personnel Moves, May 27, 2015
Novartis pharma head Epstein steps away, most recent loss in string of top-level turnovers Novartis (NYSE:NVS) is facing an upheaval in its top management, seeing 7 departures over the last 5 months as shares fell 25% since last July. Last week, Novartis pharmaceuticals head David Epstein quit as his division was split up. Earlier in the month, U.S. […]
Structural heart: Nobles Medical, HeartStitch tout cardiac suture procedures
Structural heart focused HeartStitch and Nobles Medical today touted separate procedures utilizing cardiac sutures with the company’s Hearstitch ST and Noblestitch EL devices. Nobles Medical Tech said that the NobleStitch EL device was used in the 1st percutaneous ASD closure and ASA repair and remodeling without the use of an implantable device. The NobleStitch EL device […]
Ex-Insulet CEO DeSisto is new chief exec at MannKind | Personnel Moves
MannKind Corporation said last week it picked up ex-Insulet (NSDQ:PODD) CEO Duane DeSisto as its new prez and CEO, effective January 5, 2016. DeSisto will replace interim CEO Alfred Mann, who has held the spot since November. DeSisto will also join the company’s board of directors, according to a press release from the Valencia, Calif.-based company. […]
HeartStitch touts new PFO closure method
Structural heart focused HeartStitch said today its NobleStitch EL device was used to repair 3 patients with patent forman ovale heart defects in Astana, Kazakhstan. A patent foramen ovale is a congenital heart disease in which hole in the heart that normally seals at birth remains open, and can lead to severe migraines, visual auras […]